To explore the therapeutic potential of HDAC1 inhibitor in enhancing EA-mediated tumor suppression, we meticulously assessed tumor growth curve, bioluminescence imaging, tumor weight, and systemic pro-tumorigenic cytokine levels in the TNBC transplant model (Figure 5A). Here, HDAC1 is linked to neoplasm.